Aroxybutynin and atomoxetine (AD109) for obstructive sleep apnea: a randomized phase 3 trial (SynAIRgy).

Strollo PJ Jr, Farkas R, Taranto-Montemurro L, Cronin J, Patel SR, SynAIRgy Investigators

DOI: 10.1093/ajrccm/aamag215
Published: 2026 Jul 1
Container: American journal of respiratory and critical care medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ajrccm/aamag215,
  title = {Aroxybutynin and atomoxetine (AD109) for obstructive sleep apnea: a randomized phase 3 trial (SynAIRgy).},
  author = {Strollo PJ Jr and Farkas R and Taranto-Montemurro L and Cronin J and Patel SR and SynAIRgy Investigators},
  year = {2026},
  journal = {American journal of respiratory and critical care medicine},
  doi = {10.1093/ajrccm/aamag215},
  url = {https://doi.org/10.1093/ajrccm/aamag215}
}

RIS

TY  - JOUR
TI  - Aroxybutynin and atomoxetine (AD109) for obstructive sleep apnea: a randomized phase 3 trial (SynAIRgy).
AU  - Strollo PJ Jr
AU  - Farkas R
AU  - Taranto-Montemurro L
AU  - Cronin J
AU  - Patel SR
AU  - SynAIRgy Investigators
PY  - 2026
JO  - American journal of respiratory and critical care medicine
DO  - 10.1093/ajrccm/aamag215
UR  - https://doi.org/10.1093/ajrccm/aamag215
ER  -

APA

Jr, S. P., R, F., L, T., J, C., SR, P., & Investigators, S. (2026). Aroxybutynin and atomoxetine (AD109) for obstructive sleep apnea: a randomized phase 3 trial (SynAIRgy).. American journal of respiratory and critical care medicine. https://doi.org/10.1093/ajrccm/aamag215

Source records

pubmed · retrieved 2026-09-26T06:57:22.355Z